Biotech · Public company · Knoxville, TN, US

Provectus Biopharmaceuticals, Inc.

Ticker PVCT · SEC CIK 0000315545

Track this companyFree. Adds Provectus Biopharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials30 recruiting or active

Pipeline programs5From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline5

Dacarbazine, temozolomide or talimogene laherparepvecPhase 3 · Cutaneous MelanomaClinicalTrials.gov · fetched Nov 12, 2026
PV-10 (10% rose bengal disodium)Phase 3 · Cutaneous MelanomaClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
PV-10Phase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
PV-10 (10% rose bengal disodium)Phase 1 · Cancer Metastatic to the LiverClinicalTrials.gov · fetched Nov 12, 2026

PV-10 in Combination With Pembrolizumab for Treatment of Metastatic MelanomaPHASE1_PHASE2 · UNKNOWN · started Oct 1, 2015ClinicalTrials.gov NCT02557321 · fetched Nov 12, 2026
PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous MelanomaPHASE3 · TERMINATED · started Apr 1, 2015ClinicalTrials.gov NCT02288897 · fetched Nov 12, 2026
A Study to Assess PV-10 Chemoablation of Cancer of the LiverPHASE1 · UNKNOWN · started Oct 1, 2009ClinicalTrials.gov NCT00986661 · fetched Nov 12, 2026